News

News

• Oct 19, 2022

  Our website is scheduled server maintenance

• Oct 11, 2022

  Asahi Kasei Bioprocess Launches Planova™ S20N, Strengthening High Flux and Broad Adaptability Across Platforms

• Jun 16, 2022

  The blocking model theory with consideration of the multilayer membrane structure elucidates "Planova™" virus removal filter performance

• Jun 03, 2022

  Relocation of Asahi Kasei Bioprocess Office in Brussels

• Jun 01, 2022

  Asahi Kasei Medical Completes Acquisition of Bionova Scientific, U.S.-based biopharmaceutical CDMO

• Apr 19, 2022

  Asahi Kasei Medical to acquire Bionova Scientific, U.S.-based biopharmaceutical CDMO

• Apr 13, 2022

  Asahi Kasei Medical and JSR Enter Co-promotion Agreement

• Apr 01, 2022

  Asahi Kasei Bioprocess has launched its official LinkedIn and WeChat accounts

• Feb 16, 2022

  Asahi Kasei Medical to Build New Assembly Plant for Planova™ Filters

• Feb 07, 2022

  Our website is scheduled server maintenance

• Feb 02, 2022

  Particle-based analysis unveils principal causes for inconsistency in virus filter performance! A new reliable approach to virus clearance study design with Planova™

• Jan 26, 2022

  Review paper on filter made of cuprammonium regenerated cellulose for virus removal